Impact of sarcopenia on outcomes of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation followed by surgery
Author(s) -
Gilbert Z. Murimwa,
Puja Venkat,
William Jin,
Susan Leuthold,
Kujtim Latifi,
Khaldoun Almhanna,
José M. Pimiento,
Jacques-Pierre Fontaine,
Sarah E. Hoffe,
Jessica M. Frakes
Publication year - 2017
Publication title -
journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.084
H-Index - 39
eISSN - 2219-679X
pISSN - 2078-6891
DOI - 10.21037/jgo.2017.06.11
Subject(s) - medicine , sarcopenia , common terminology criteria for adverse events , radiation therapy , esophageal cancer , logistic regression , cancer , psoas muscles , cohort , chemoradiotherapy , radiology , surgery
Sarcopenia is an independent predictor of clinical outcomes in multiple gastrointestinal cancers. Total psoas area (TPA), as measured on a single cross-sectional CT image at the L4 vertebral body level, has been correlated with sarcopenia. We sought to evaluate whether TPA was predictive of acute grade ≥3 toxicity, pathologic response, and overall survival in patients with locally advanced esophageal cancer receiving tri-modality therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom